Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.060 Biomarker phenotype BEFREE Expression of AXL and MER on both immune and tumor cells increased during tumor progression. 30723115 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.060 Biomarker phenotype BEFREE Taken together, our results demonstrate for the first time that mixtures of persistent organic pollutants present in follicular fluids may induce granulosa tumor progression through IGF1R and GPR30 by acting as mitogenic factors in granulosa cells. 30414542 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.060 Biomarker phenotype BEFREE The GPER1/GPR30 is a membrane estrogen receptor (mER) that binds 17β-estradiol (17β-E) with high affinity and is thought to play a role in cancer progression and cardiovascular health. 28465157 2018
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.060 Biomarker phenotype BEFREE The G protein estrogen receptor GPER/GPR30 mediates estrogen action in breast cancer cells as well as in breast cancer-associated fibroblasts (CAFs), which are key components of microenvironment driving tumor progression. 29212519 2017
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.060 Biomarker phenotype BEFREE Collectively, these data demonstrate that E2β action via GPER-1 enhances cellular adhesivity and FN matrix assembly and allows for anchorage-independent growth, cellular events that may allow for cellular survival, and tumor progression. 25096985 2014
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
0.060 AlteredExpression phenotype BEFREE Our data suggest that GPER may be included among the transduction mediators involved by estrogens in regulating FASN expression and activity in cancer cells and cancer-associated fibroblasts that strongly contribute to cancer progression. 23135268 2012